Youthfulness of marrow Adipoq+ cells maintained by Cbfβ facilitates stem cell-based bone repair

Tiannan Huang , Shali Wu , Wei Qian , Ruiying Chen , Erman Chen , Meizhu Wang , Cui Zhang , Chenhe Zhou , Luyang Yu , Mengjie Wu , Yi-Ping Li , Mengrui Wu

Bone Research ›› 2026, Vol. 14 ›› Issue (1) : 82

PDF
Bone Research ›› 2026, Vol. 14 ›› Issue (1) :82 DOI: 10.1038/s41413-026-00568-8
Article
research-article
Youthfulness of marrow Adipoq+ cells maintained by Cbfβ facilitates stem cell-based bone repair
Author information +
History +
PDF

Abstract

Exhaustion of skeletal stem and progenitor cells (SSPCs) drives age-related delays in fracture repair, yet the upstream regulators of SSPC maintenance are unclear. We identify that core-binding factor β (Cbfβ) in bone marrow Adipoq+ cells (BMACs) is essential for maintaining SSPC number and function. Cbfβ deletion in BMACs (CKO) leads to SSPC depletion, including periosteal populations, and impairs bicortical fracture healing in mice. Multi-omics (RNA-seq, CUT&Tag-seq, and ATAC-seq) reveal that Cbfβ preserves chromatin accessibility at DNA repair loci, maintaining genomic stability, preventing BMAC senescence, and mitigating the senescence-associated secretory phenotype (SASP). Senolytic therapy alleviates BMAC senescence, restores SSPC populations, and improves bone repair in CKO mice. In both humans and mice, Cbfβ expression declines with aging, accompanied by increased BMAC senescence. AAV-mediated Cbfβ overexpression restores aging-related bone repair and SSPC decline. These findings reveal a novel mechanism in which Cbfβ in BMACs regulates SSPC maintenance via a senescence/SASP axis, offering a potential therapeutic strategy for age-related bone repair deficits.

Cite this article

Download citation ▾
Tiannan Huang, Shali Wu, Wei Qian, Ruiying Chen, Erman Chen, Meizhu Wang, Cui Zhang, Chenhe Zhou, Luyang Yu, Mengjie Wu, Yi-Ping Li, Mengrui Wu. Youthfulness of marrow Adipoq+ cells maintained by Cbfβ facilitates stem cell-based bone repair. Bone Research, 2026, 14 (1) : 82 DOI:10.1038/s41413-026-00568-8

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Saul D, Khosla S. Fracture healing in the setting of endocrine diseases, aging, and cellular senescence. Endocr. Rev., 2022, 43: 984-1002

[2]

Gibon E, Lu L, Goodman SB. Aging, inflammation, stem cells, and bone healing. Stem Cell Res. Ther., 2016, 7: 44

[3]

Melis S, Trompet D, Chagin AS, Maes C. Skeletal stem and progenitor cells in bone physiology, ageing and disease. Nat. Rev. Endocrinol., 2025, 21: 135-153

[4]

Ambrosi TH, et al.. Aged skeletal stem cells generate an inflammatory degenerative niche. Nature, 2021, 597: 256-262

[5]

Ambrosi TH, et al.. Distinct skeletal stem cell types orchestrate long bone skeletogenesis. eLife, 2021, 10 ArticleID: e66063

[6]

Josephson AM, et al.. Age-related inflammation triggers skeletal stem/progenitor cell dysfunction. Proc. Natl. Acad. Sci., 2019, 116: 6995-7004

[7]

Butler, M. G. K., Ambrosi, T. H., Murphy, M. P. & Chan, C. K. F. Aging of skeletal stem cells. Adv. Geriatr. Med. Res.4, e220006 (2022).

[8]

Bukowska J, et al.. Bone marrow adipocyte developmental origin and biology. Curr. Osteoporos. Rep., 2018, 16: 312-319

[9]

de Paula FJA, Rosen CJ. Marrow adipocytes: origin, structure, and function. Annu. Rev. Physiol., 2020, 82: 461-484

[10]

Tencerova M, et al.. Obesity-associated hypermetabolism and accelerated senescence of bone marrow stromal stem cells suggest a potential mechanism for bone fragility. Cell Rep., 2019, 27: 2050-2062.e2056

[11]

Tencerova M, et al.. High-fat diet-induced obesity promotes expansion of bone marrow adipose tissue and impairs skeletal stem cell functions in mice. J. Bone Miner. Res., 2018, 33: 1154-1165

[12]

Zhong, L. et al. Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment. eLife9, e54695 (2020).

[13]

Yu, W. et al. Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss. J. Clin. Invest. 131, e140214 (2021).

[14]

Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell, 2014, 15: 154-168

[15]

Jeffery EC, Mann TLA, Pool JA, Zhao Z, Morrison SJ. Bone marrow and periosteal skeletal stem/progenitor cells make distinct contributions to bone maintenance and repair. Cell Stem Cell, 2022, 29: 1547-1561.e1546

[16]

Hu Y, et al.. RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss. EMBO Rep., 2021, 22 ArticleID: e52481

[17]

Liu YL, Tang XT, Shu HS, Zou W, Zhou BO. Fibrous periosteum repairs bone fracture and maintains the healed bone throughout mouse adulthood. Dev. Cell, 2024, 59: 1192-1209.e1196

[18]

Zhong L, Yao L, Seale P, Qin L. Marrow adipogenic lineage precursor: a new cellular component of marrow adipose tissue. Best. Pract. Res. Clin. Endocrinol. Metab., 2021, 35 ArticleID: 101518

[19]

Zhou BO, et al.. Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF. Nat. Cell Biol., 2017, 19: 891-903

[20]

Zhang Z, et al.. Bone marrow adipose tissue-derived stem cell factor mediates metabolic regulation of hematopoiesis. Haematologica, 2019, 104: 1731-1743

[21]

Gao H, et al.. Bone marrow adipoq+ cell population controls bone mass via sclerostin in mice. Signal Transduct. Target. Ther., 2023, 8: 265

[22]

Zhong, L. et al. Csf1 from marrow adipogenic precursors is required for osteoclast formation and hematopoiesis in bone. eLife12, e82112 (2023).

[23]

Zou W, et al.. Ablation of fat cells in adult mice induces massive bone gain. Cell Metab., 2020, 32: 801-813.e806

[24]

Ambrosi TH, et al.. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem Cell, 2017, 20: 771-784.e776

[25]

Inoue, K. et al. Bone marrow Adipoq-lineage progenitors are a major cellular source of M-CSF that dominates bone marrow macrophage development, osteoclastogenesis, and bone mass. eLife12, e82118 (2023).

[26]

Lu J, et al.. Bone marrow adipogenic lineage precursors are the major regulator of bone resorption in adult mice. Bone Res., 2025, 13: 39

[27]

Caers J, et al.. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia, 2007, 21: 1580-1584

[28]

Mattiucci D, et al.. Bone marrow adipocytes support hematopoietic stem cell survival. J. Cell. Physiol., 2018, 233: 1500-1511

[29]

Gasparrini M, Rivas D, Elbaz A, Duque G. Differential expression of cytokines in subcutaneous and marrow fat of aging C57BL/6J mice. Exp. Gerontol., 2009, 44: 613-618

[30]

Liu LF, Shen WJ, Ueno M, Patel S, Kraemer FB. Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes. BMC Genom., 2011, 12 ArticleID: 212

[31]

Li, Z. et al. Constitutive bone marrow adipocytes suppress local bone formation. JCI Insight7, e160915 (2022).

[32]

Fairfield H, et al.. Myeloma-modified adipocytes exhibit metabolic dysfunction and a senescence-associated secretory phenotype. Cancer Res., 2021, 81: 634-647

[33]

Xie L, et al.. PCLAF induces bone marrow adipocyte senescence and contributes to skeletal aging. Bone Res., 2024, 12: 38

[34]

Chandra A, et al.. Bone marrow adiposity in models of radiation- and aging-related bone loss is dependent on cellular senescence. J. Bone Miner. Res., 2022, 37: 997-1011

[35]

Liu X, et al.. Oxylipin-PPARγ-initiated adipocyte senescence propagates secondary senescence in the bone marrow. Cell Metab., 2023, 35: 667-684.e666

[36]

Gorgoulis V, et al.. Cellular senescence: defining a path forward. Cell, 2019, 179: 813-827

[37]

Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat. Med., 2015, 21: 1424-1435

[38]

Ogrodnik M, et al.. Guidelines for minimal information on cellular senescence experimentation in vivo. Cell, 2024, 187: 4150-4175

[39]

Seo W, Taniuchi I. The roles of RUNX family proteins in development of immune cells. Mol. Cells, 2020, 43: 107-113

[40]

Ito Y, Bae SC, Chuang LS. The RUNX family: developmental regulators in cancer. Nat. Rev. Cancer, 2015, 15: 81-95

[41]

Yoshida CA, et al.. Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat. Genet., 2002, 32: 633-638

[42]

Lim KE, et al.. Core binding factor β of osteoblasts maintains cortical bone mass via stabilization of Runx2 in mice. J. Bone Miner. Res., 2015, 30: 715-722

[43]

Wu M, et al.. Deletion of core-binding factor β (Cbfβ) in mesenchymal progenitor cells provides new insights into Cbfβ/Runxs complex function in cartilage and bone development. Bone, 2014, 65: 49-59

[44]

Tian F, et al.. Core binding factor beta (Cbfβ) controls the balance of chondrocyte proliferation and differentiation by upregulating Indian hedgehog (Ihh) expression and inhibiting parathyroid hormone-related protein receptor (PPR) expression in postnatal cartilage and bone formation. J. Bone Miner. Res., 2014, 29: 1564-1574

[45]

Wu M, et al.. Chondrocyte-specific knockout of Cbfβ reveals the indispensable function of Cbfβ in chondrocyte maturation, growth plate development and trabecular bone formation in mice. Int. J. Biol. Sci., 2014, 10: 861-872

[46]

Chen W, et al.. Cbfβ deletion in mice recapitulates cleidocranial dysplasia and reveals multiple functions of Cbfβ required for skeletal development. Proc. Natl. Acad. Sci. USA, 2014, 111: 8482-8487

[47]

Wu M, et al.. Cbfβ governs osteoblast-adipocyte lineage commitment through enhancing β-catenin signaling and suppressing adipogenesis gene expression. Proc. Natl. Acad. Sci. USA, 2017, 114: 10119-10124

[48]

Beyltjens T, et al.. Heterozygous pathogenic variants involving CBFB cause a new skeletal disorder resembling cleidocranial dysplasia. J. Med. Genet., 2023, 60: 498-504

[49]

Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat. Rev. Rheumatol., 2015, 11: 45-54

[50]

Chan CK, et al.. Identification and specification of the mouse skeletal stem cell. Cell, 2015, 160: 285-298

[51]

Morikawa S, et al.. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J. Exp. Med., 2009, 206: 2483-2496

[52]

Xu J, et al.. PDGFRα reporter activity identifies periosteal progenitor cells critical for bone formation and fracture repair. Bone Res., 2022, 10: 7

[53]

Saul, D. et al. Modulation of fracture healing by the transient accumulation of senescent cells. eLife10, e69958 (2021).

[54]

Zou NY, et al.. Age-related secretion of grancalcin by macrophages induces skeletal stem/progenitor cell senescence during fracture healing. Bone Res., 2024, 12: 6

[55]

Liu, J. et al. Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice. J. Clin. Invest.132, e148073 (2022).

[56]

Hofbauer, L. C., Baschant, U. & Hofbauer, C. Targeting senescent cells to boost bone fracture healing. J. Clin. Invest.134, e181974 (2024).

[57]

Hewitt G, et al.. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun., 2012, 3 ArticleID: 708

[58]

Cosgrove BD, et al.. Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat. Med., 2014, 20: 255-264

[59]

Saul, D. et al. Osteochondroprogenitor cells and neutrophils expressing p21 and senescence markers modulate fracture repair. J. Clin. Invest.134, e179834 (2024).

[60]

Moiseeva V, et al.. Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration. Nature, 2023, 613: 169-178

[61]

Admasu TD, Rae M, Stolzing A. Dissecting primary and secondary senescence to enable new senotherapeutic strategies. Ageing Res. Rev., 2021, 70 ArticleID: 101412

[62]

Xu M, et al.. Senolytics improve physical function and increase lifespan in old age. Nat. Med., 2018, 24: 1246-1256

[63]

Schafer MJ, et al.. Cellular senescence mediates fibrotic pulmonary disease. Nat. Commun., 2017, 8 ArticleID: 14532

[64]

Farr JN, et al.. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med., 2017, 23: 1072-1079

[65]

Nelson G, et al.. A senescent cell bystander effect: senescence-induced senescence. Aging Cell, 2012, 11: 345-349

[66]

Xu M, et al.. Targeting senescent cells enhances adipogenesis and metabolic function in old age. eLife, 2015, 4 ArticleID: e12997

[67]

Grüneboom A, et al.. A network of trans-cortical capillaries as mainstay for blood circulation in long bones. Nat. Metab., 2019, 1: 236-250

[68]

Britton S, et al.. ATM antagonizes NHEJ proteins assembly and DNA-ends synapsis at single-ended DNA double strand breaks. Nucleic Acids Res., 2020, 48: 9710-9723

[69]

Chang HHY, Pannunzio NR, Adachi N, Lieber MR. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat. Rev. Mol. Cell Biol., 2017, 18: 495-506

[70]

Chen S, et al.. Structural basis of long-range to short-range synaptic transition in NHEJ. Nature, 2021, 593: 294-298

[71]

Xu G, et al.. REV7 counteracts DNA double-strand break resection and affects PARP inhibition. Nature, 2015, 521: 541-544

[72]

Scully R, Panday A, Elango R, Willis NA. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat. Rev. Mol. Cell Biol., 2019, 20: 698-714

[73]

Boersma V, et al.. MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5′ end resection. Nature, 2015, 521: 537-540

[74]

Paniagua I, et al.. MAD2L2 promotes replication fork protection and recovery in a shieldin-independent and REV3L-dependent manner. Nat. Commun., 2022, 13 ArticleID: 5167

[75]

Li Q, et al.. Obesity and hyperinsulinemia drive adipocytes to activate a cell cycle program and senesce. Nat. Med., 2021, 27: 1941-1953

[76]

Wang Q, et al.. Cell cycle regulation by alternative polyadenylation of CCND1. Sci. Rep., 2018, 8 ArticleID: 6824

[77]

Barone G, et al.. Human CDK18 promotes replication stress signaling and genome stability. Nucleic Acids Res., 2016, 44: 8772-8785

[78]

Peng XP, Zhao X. The multi-functional Smc5/6 complex in genome protection and disease. Nat. Struct. Mol. Biol., 2023, 30: 724-734

[79]

Stamatiou K, et al.. Ki-67 is necessary during DNA replication for fork protection and genome stability. Genome Biol., 2024, 25 ArticleID: 105

[80]

Wang D, et al.. The transcription factor Runx3 establishes chromatin accessibility of cis-regulatory landscapes that drive memory cytotoxic T lymphocyte formation. Immunity, 2018, 48: 659-674.e656

[81]

Bakshi R, et al.. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. J. Cell. Physiol., 2010, 225: 569-576

[82]

Siraj Y, et al.. IGFBP7 is a key component of the senescence-associated secretory phenotype (SASP) that induces senescence in healthy cells by modulating the insulin, IGF, and activin A pathways. Cell Commun. Signal., 2024, 22: 540

[83]

Zhang L, et al.. IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma. Cell Biosci., 2019, 9: 44

[84]

Evdokimova V, et al.. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors. Sci. Signal., 2012, 5: ra92

[85]

Wang Y, Bikle DD, Chang W. Autocrine and paracrine actions of IGF-I signaling in skeletal development. Bone Res., 2013, 1: 249-259

[86]

Rosen CJ, Horowitz MC. Nutrient regulation of bone marrow adipose tissue: skeletal implications of weight loss. Nat. Rev. Endocrinol., 2023, 19: 626-638

[87]

Li Z, Rosen CJ. The multifaceted roles of bone marrow adipocytes in bone and hematopoietic homeostasis. J. Clin. Endocrinol. Metab., 2023, 108: e1465-e1472

[88]

Xu W, et al.. Clinical implications of bone marrow adiposity identified by phenome-wide association and Mendelian randomization in the UK Biobank. Nat. Commun., 2025, 16 ArticleID: 8332

[89]

Jiang S, Knapstein P, Donat A, Tsitsilonis S, Keller J. An optimized protocol for a standardized, femoral osteotomy model to study fracture healing in mice. STAR Protoc., 2021, 2 ArticleID: 100798

Funding

The Key Project of Zhejiang Provincial Medical and Health Science and Technology Plan WKJ-ZJ-2443

National Natural Science Foundation of China (National Science Foundation of China)(82001461)

Application Program for Chinese Manned Space Station YYWT-0901-EXP-06; NSM0617

National Key Research and Development Program of China 2023YFC2509200 Zhejiang Science Foundation for Distinguished Young Scholars LR24H140001

Zhejiang Provincial “Ten Thousand Plan” Outstanding Young Scholar National Key Research and Development Program of China 2023YFA1800602 The Key Program of the Zhejiang Provincial Natural Science Foundation of China under the Huadong Medicine Joint Fund LHDM25H280002 Application Program for Chinese Manned Space Station CMSS-2024-1-A-019

RIGHTS & PERMISSIONS

The Author(s)

PDF

4

Accesses

0

Citation

Detail

Sections
Recommended

/